Clinical trial looks at tramadol for opioid withdrawal

July 12, 2017

A randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential research setting.

Opioid use disorder is a public health problem that has contributed to unprecedented levels of overdose deaths. Detoxification - or medically supervised withdrawal - is a widely used treatment for opioid use disorder. However, failing to adequately manage opioid withdrawal symptoms can contribute to people leaving treatment.

Clonidine and buprenorphine are two medications widely used to manage opioid withdrawal. Tramadol hydrochloride is a promising alternative option for effective opioid use disorder treatment, according to the article.

Kelly E. Dunn, Ph.D., of the Johns Hopkins University School of Medicine, Baltimore, and coauthors conducted a in a residential research setting with 103 patients, mostly men, with opioid use disorder. During a seven-day taper, clonidine, buprenorphine or tramadol hydrochloride extended-release, which is an approved analgesic with low abuse potential, were used.

The clinical trial showed tramadol extended-release suppressed withdrawal more than clonidine and was comparable to buprenorphine during a residential tapering program, according to the article.

The study notes some limitations, including a primarily male sample and a lack of specific information regarding past 30-day use of other illicit drugs and alcohol.

"These data suggest that tramadol ER is a promising and valuable medication for the management of opioid withdrawal in patients undergoing treatment for OUD [ use disorder]. Future studies should evaluate whether relapse varies following supervised withdrawal with tramadol ER vs. other medications and whether ER can be used to transition patients to naltrexone ," the article concludes.

Explore further: Injectable therapy blocks opioid euphoria, withdrawal symptoms in trial

More information: JAMA Psychiatry (2017). doi:10.1001/ jamapsychiatry.2017.1838

Related Stories

Injectable therapy blocks opioid euphoria, withdrawal symptoms in trial

June 26, 2017
A study led by investigators in the University of Kentucky Center on Drug and Alcohol Research (CDAR) has demonstrated a weekly injectable formulation of buprenorphine, CAM2038, suppresses symptoms of withdrawal in patients ...

Study examines opioid use in patients with rheumatoid arthritis

June 21, 2017
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly. By 2014, 41% of rheumatoid arthritis patients were regular opioid users.

NIH-led workshop addresses opioid misuse during pregnancy

June 9, 2017
Research is essential to determining how best to screen pregnant women for opioid use disorder, to treat pregnant women who have the disorder, and to care for infants as they experience withdrawal symptoms, according to experts ...

Rural physicians report significant barriers in treating opioid use disorder

July 11, 2017
More than half of rural counties in the United States lack a physician trained and waivered by the Drug Enforcement Agency to treat opioid use disorder using Buprenorphine Maintenance Treatment. Furthermore, many physicians ...

Opioid dependence can start in just a few days

March 16, 2017
(HealthDay)—Doctors who limit the supply of opioids they prescribe to three days or less may help patients avoid the dangers of dependence and addiction, a new study suggests.

Researchers developing mobile app for opioid detoxification

February 7, 2017
In the midst of the opioid epidemic, an estimated 1.5 million Americans seek treatment annually in an effort to avoid the life-threatening effects of opioid use disorder and improve their quality of life.

Recommended for you

Thinking about germs makes people concerned about how they look

December 18, 2017
Simply thinking about potential infection seems to increase people's concerns about their own physical appearance, especially if they are chronic germ worriers, according to new research in Psychological Science. The findings ...

Teens who help strangers have more confidence, study finds

December 18, 2017
Tis the season for helping at a soup kitchen, caroling at a care facility or shoveling a neighbor's driveway.

How much people earn is associated with how they experience happiness

December 18, 2017
People who earn more money tend to experience more positive emotions focused on themselves, while people who earn less take greater pleasure in their relationships and ability to connect with others, according to research ...

Could cognitive interventions be useful in treating depression?

December 18, 2017
A new study by experimental psychologists from the University of Bristol has examined whether cognitive bias modification (CBM) for facial interpretation, a digital health intervention that changes our perception for emotional ...

Suicidal thoughts rapidly reduced with ketamine, finds study

December 14, 2017
Ketamine was significantly more effective than a commonly used sedative in reducing suicidal thoughts in depressed patients, according to researchers at Columbia University Medical Center (CUMC). They also found that ketamine's ...

Do bullies have more sex?

December 14, 2017
Adolescents who are willing to exploit others for personal gain are more likely to bully and have sex than those who score higher on a measure of honesty and humility. This is according to a study in Springer's journal Evolutionary ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Jul 13, 2017
Why use empiricals when 250mg of healthy adult male facial skin surface lipid pheromone rubbed from a man's face onto ordinary fresh, new, un-chewed chewing gum cures oxycodone addiction? Take care not to breathe the fumes, they cause suspicion, superstition, arrogance, stupidity, and jealousy. Addiction is a symptom of paternal facial pheromone deficiency, easily remedied.
Captain Stumpy
1 / 5 (1) Jul 13, 2017
@lying pseudoscience fraud bubba the quack
cures oxycodone addiction
there is absolutely no scientific evidence that supports your assertions in any journal, anywhere

this is called a religious belief

religion often thinks that repeating a lie makes it more true
this may work with cults, but it is not in any way science, nor does it work with people who are capable of seeking valid information to substantiate a claim

considering your attempt to sell your pseudoscience, you must be starting your own cult and are seeking acolytes

enjoy your jail time for fraud
reported

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.